VERA FY 2024 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$167M

Net Income

-$152M

EPS (Diluted)

$-2.75

Cash Flow

Operating Cash Flow

-$135M

Free Cash Flow

-$136M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$656M

Total Liabilities

$79M

Stockholders' Equity

$577M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$167M	-$102M	-63.9%
Net Income	-$152M	-$96M	-58.5%